We integrate strategic solutions, expert consultants flexible FSP models, and full-service development into a single, uninterrupted workflow.
End-to-end delivery
Clinical development
Strategic solutions
Independent Assurance
We bring immediate scientific depth to your protocol through dedicated teams across five core therapeutic areas.
Therapeutic expertise
Built on nordic ethics
We combine 30 years of global trial execution with scandinavian transparency, replacing legacy bureaucracy with direct, scientist-to-scientist alignment.
Company
Connect
Circulating tumor DNA (ctDNA) refers to small fragments of DNA that are released into the bloodstream by cancer cells. Analyzing ctDNA can provide valuable information for cancer diagnosis, monitoring, and treatment decisions.
